Tracking Wegovy: five dose steps, one honest record
Updated August 17, 2026 · 6 min read
Wegovy (semaglutide 2.4 mg) has the longest on-ramp of the major GLP-1 weight-loss medications: five dose steps — 0.25, 0.5, 1.0, 1.7, and finally 2.4 mg weekly — each typically held four weeks. That's roughly four months of scheduled change before you even reach maintenance, and each step can feel different. This is precisely the stretch where a tracker app earns its place. (DreamMe is our app; the guidance below applies regardless of which tracker you pick.)
Why the Wegovy ladder is the whole story
In pooled analyses of semaglutide's clinical trials, GI side effects were mostly mild-to-moderate and transient — and they clustered during and shortly after dose escalations. Typical episodes resolved in days (nausea's median duration was about a week; constipation was the stubborn one, lasting weeks longer). Practically, that means each of your five steps has a predictable shape: a possible bumpy first stretch, then settling. Without dated logs, five of those bumps blur into "Wegovy makes me feel sick." With them, you can see "each step cost me about four rough days, and 1.7 mg was the hardest" — which is exactly what your provider needs to hear when deciding whether to hold a step longer.
What to track on Wegovy
- Shots and doses— with the step you're on and the date you moved up. Site rotation too.
- Side effects with severity, daily— especially the first two weeks of each new step. This is the data that distinguishes "expected escalation bump" from "persisting problem."
- Weight, weekly, same day of your cycle — semaglutide levels peak one to three days after the shot, and appetite often drifts back late in the week, so a consistent weigh-in day keeps the trend honest.
- Protein and fluids — appetite suppression makes protein shortfalls and mild dehydration the default failure mode; both are behind several common complaints (fatigue, headache, constipation). See our protein guide.
Safety note: severe or persistent abdominal pain, vomiting that prevents keeping fluids down, or right-upper-belly pain with fever are prompt-medical- contact situations, not tracking situations.
How DreamMe handles Wegovy
DreamMe is built for exactly this cadence: weekly shot reminders, dose history that shows each step and how long you held it, day-by-day side-effect logging that feeds a weekly report (with anonymized peer context, never dose advice), photo and voice meal logging with protein and water goals, and a one-tap doctor PDF for titration check-ins. Still choosing an app? The full comparison covers the field honestly.
Frequently asked questions
How long does it take to reach the full Wegovy dose?
The label's standard schedule reaches the 2.4 mg maintenance dose in about 17 weeks (five steps, four weeks each) — but many providers go slower on purpose, holding a step longer if side effects need time to settle. Your prescriber's plan wins; a tracker just keeps the record straight.
How much weight do people lose on Wegovy?
In the STEP 1 trial, participants lost on average about 15% of body weight over 68 weeks. That's a trial average, not a promise — and week-12 progress in trials was closer to 6%, which is worth knowing before you judge your own early pace.
Is Wegovy the same as Ozempic?
Same molecule (semaglutide), different label and doses: Wegovy is approved for weight management with a 2.4 mg maintenance dose; Ozempic is approved for type 2 diabetes. If you're on Ozempic, see our Ozempic tracking guide.
What helps with nausea when moving up a dose?
Common self-care guidance from obesity-medicine sources: smaller, blander, lower-fat meals; sipping fluids through the day; and giving it time — in trials, nausea episodes around dose changes typically lasted days, not months. If nausea is severe, or you can't keep fluids down, contact your provider rather than pushing through.
Ready to make your GLP-1 journey easier?
Track shots, meals, side effects, and progress with Sushi by your side — on iPhone and Android, in 12 languages.
Try DreamMe